Beyond the Crop Protection Patent Cliff: How Competitive Advantage Shifts After Patent Expiration
When a blockbuster crop protection molecule loses patent protection, the industry’s interpretation is usually predictable. The innovator loses exclusivity. Generic manufacturers expand. Prices decline. Margins compress.
But perhaps the industry is looking at the wrong event. Patent expiry is not the structural change. It is merely the moment when competitive advantage begins to migrate. Understanding where competitive advantage moves after exclusivity ends may become far more important than understanding why exclusivity ended in the first place.
Figure 1. Competitive Advantage Migration After Patent Expiry
Patent Protection
│
▼
Competitive Advantage (Molecule)
│
▼
Patent Expiry
│
▼
Manufacturing Advantage
│
▼
Capacity Expansion / Commoditization
│
▼
Capability Advantage
• Formulation
• Registration
• Brand
• Agronomy
• Local Team
• Supply Chain
│
▼
Customer Value
FMC Offers Evidence of this Migration
FMC’s second-quarter results provide an opportunity to observe this transition in real time.
The company reported second-quarter revenue of US$867 million, down 17%, while adjusted EBITDA declined 26% year-over-year. Branded Rynaxypyr sales remained comparatively resilient, while orders from diamide partners weakened.
The numbers suggest that not every capability is losing value at the same rate. The parts of the business easiest to replicate are experiencing the greatest pressure, while capabilities closer to customers — including formulation, regulatory assets, commercial execution and brand — remain comparatively more resilient.
Value is not disappearing. It is moving.
Table 1. FMC Q2, 2026 Performance
| Indicator | YoY |
| Revenue | -17% |
| Adjusted EBITDA | -26% |
| Diamide partner orders | Declined |
| Branded Rynaxypyr | Relatively resilient |
China Illustrates the First Migration
By July 2026, more than 1,000 pesticide registrations containing chlorantraniliprole had been approved in China, based on verification of China’s official pesticide registration database.
Manufacturing capability has become significantly more accessible than during the patent period. As manufacturing becomes broadly available, companies begin competing on something different — not simply what they produce, but how they create value around what they produce.
Reading the Industry Differently
The current discussion around patent expiry, biologicals, AI and open innovation can be taken one step further by asking a different question: Where does competitive advantage migrate after exclusivity weakens?
The answer appears increasingly clear. Value moves beyond patents. It moves beyond manufacturing. It begins concentrating in capabilities that remain difficult to reproduce:
- Formulation
- Registration
- Agronomy
- Brand
- Supply responsiveness
- Customer relationships
- Local execution
Together, these increasingly become the next source of differentiation.
Where Value Goes Next
The patent cliff is not simply a legal event. Nor is it merely a transfer of market share from originators to generic manufacturers. It is a redistribution of competitive advantage.
For originators, the challenge is to transform scientific, regulatory and commercial assets into a viable post-patent system. For generic manufacturers, efficient production may secure market entry, but sustainable value will increasingly depend on differentiated formulations, independently developed processes, registrations, responsive supply, commercial excellence and market credibility. For distributors and regional companies, the opportunity lies in combining diversified supply with agronomy, customer relationships and local execution.
The patent cliff is the visible event. Capability migration is the structural change beneath it. One concerns intellectual property. The other concerns the future of competitive advantage.
The next era of competition will not be defined by who owns the molecule. It will be defined by who creates the greatest value after exclusivity ends.
Get The Newsletter Today!
